Current status and future prospects for a vaccine against American trypanosomiasis (Q36350576)

13 August 2017

1 reference

title

Current status and future prospects for a vaccine against American trypanosomiasis (English)

1 reference

13 August 2017

0 references

0 references

Nisha Garg

1

1 reference

13 August 2017

Vandanajay Bhatia

series ordinal

2

1 reference

13 August 2017

language of work or name

1 reference

1 December 2005

1 reference

Expert Review of Vaccines

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

6

1 reference

13 August 2017

867-880

1 reference

American trypanosomiasis (Chagas' disease)--a tropical disease now in the United States

13 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Parasitic diseases of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Specific antibodies to Trypanosoma cruzi among blood donors in Los Angeles, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Emerging infectious threats to the blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Chagas disease in a domestic transmission cycle, southern Texas, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Trypanosoma cruzi: presence of the two major phylogenetic lineages and of several lesser discrete typing units (DTUs) in Chile and Paraguay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Predominance of Trypanosoma cruzi lineage I in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Trypanosoma cruzi: a considerable phylogenetic divergence indicates that the agent of Chagas disease is indigenous to the native fauna of the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Chagas' heart disease: clinical-pathological correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Clinical management of chronic Chagas cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Molecular diagnosis of experimental Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Safety of the blood supply in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Autoimmunity in Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

The significance of autoimmunity in the pathogenesis of chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Pathophysiology of the heart in Chagas' disease: current status and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

PCR-based diagnosis for Chagas' disease in Bolivian children living in an active transmission area: comparison with conventional serological and parasitological diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Prevalence of circulating Trypanosoma cruzi detected by polymerase chain reaction in patients with Chagas' cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Persistence of Trypanosoma cruzi in chronic chagasic cardiopathy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Trypanosoma cruzi: partial prevention of the natural infection of guinea pigs with a killed parasite vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Correspondence: Transfer of immunity to T. cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Resistance of mice immunized with irradiated and lyophilized stages of Trypanosoma cruzi to infections with metacyclics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

The targets of the lytic antibody response against Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Molecular cloning of the gene encoding the 83 kDa amastigote surface protein and its identification as a member of the Trypanosoma cruzi sialidase superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Intracellular growth and metacyclogenesis defects in Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Overexpression of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, is associated with enhanced metacyclogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Immunization of marmosets with Trypanosoma cruzi cell surface glycoprotein (GP90).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Trypanosoma cruzi glycoprotein of M(r) 56,000 characterization and assessment of its potential to protect against fatal parasite infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Paraflagellar rod protein-specific CD8+ cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Immunization with recombinant paraflagellar rod protein induces protective immunity against Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

21 January 2018

Plasmid DNA vaccination

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Structural and functional properties of Trypanosoma trans-sialidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

LYT1 protein is required for efficient in vitro infection by Trypanosoma cruzi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Gene expression microarrays: a 21st century tool for directed vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

DNA microarrays for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Gene expression profile in Neisseria meningitidis and Neisseria lactamica upon host-cell contact: from basic research to vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Identification of specific cellular genes up-regulated late in adenovirus type 12 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Comparative genomics of Staphylococcus aureus musculoskeletal isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Microarray profiling of gene expression during trypomastigote to amastigote transition in Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

DNA microarrays for comparative genomics and analysis of gene expression in Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Mechanisms of development of immunosuppression during Trypanosoma infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

Simultaneous occurrence of acute myocarditis and reactivated Chagas' disease in a patient with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.6.867

21 January 2018

Identifiers

DOI

10.1586/14760584.4.6.867

1 reference

release_jbjzrqist5fgzcg5ycyhoq4goy

13 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jbjzrqist5fgzcg5ycyhoq4goy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference